Increase in cathepsin K gene expression in Duchenne muscular dystrophy skeletal muscle

被引:1
|
作者
Kimura, Shigemi [1 ,3 ,4 ]
Miyake, Noriko [6 ]
Ozasa, Shiro [2 ]
Ueno, Hiroe [1 ]
Ohtani, Yoshinobu [1 ]
Takaoka, Yutaka [3 ,4 ,5 ]
Nishino, Ichizo [7 ]
机构
[1] Kumamoto Takumadai Rehabil Hosp, Dept Pediat, 8-2-1 Obiyama,Chuo Ku, Kumamoto 8620924, Japan
[2] Kumamoto Univ Hosp, Dept Pediat, Kumamoto, Japan
[3] Toyama Univ Hosp, Data Sci Ctr Med & Hosp Management, Toyama, Japan
[4] Kobe Univ, Dept Med Syst, Grad Sch Med, Kobe, Japan
[5] Kobe Tokiwa Univ, Fac Hlth Sci, Kobe, Japan
[6] Natl Ctr Global Hlth & Med, Res Inst, Dept Human Genet, Tokyo, Japan
[7] Natl Inst Neurosci, Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Tokyo, Japan
关键词
Cathepsin K; Duchenne muscular dystrophy; gene expression; RNA sequence; therapy; MU-CRYSTALLIN; STRINGTIE; MATRIX; HISAT;
D O I
10.1111/neup.12995
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Dystrophinopathy is caused by alterations in the dystrophin gene. The severe phenotype, Duchenne muscular dystrophy (DMD), is caused by a lack of dystrophin in skeletal muscles, resulting in necrosis and regenerating fibers, inflammatory cells, and muscle fibrosis. Progressive muscle weakness is a characteristic finding of this condition. Here, we encountered a rare case of a 10-year-old patient with asymptomatic dystrophinopathy with no dystrophin expression and investigated the reason for the absence of muscle weakness to obtain therapeutic insights for DMD. Using RNA-seq analysis, gene expression in skeletal muscles was compared among patients with asymptomatic dystrophinopathy, three patients with typical DMD, and two patients without dystrophinopathy who were leading normal daily lives. Cathepsin K (CTSK), myosin heavy chain 3 (MYH3), and nodal modulator 3-like genes exhibited a >8-fold change, whereas crystallin mu gene (CRYM) showed a <1/8-fold change in patients with typical DMD compared with their expression in the patient with asymptomatic dystrophinopathy. Additionally, CTSK and MYH3 expression exhibited a >16-fold change (P < 0.01), whereas CRYM expression showed a <1/16-fold change (P < 0.01) in patients with typical DMD compared with their expression in those without dystrophinopathy. CTSK plays an essential role in skeletal muscle loss, fibrosis, and inflammation in response to muscles injected with cardiotoxin, one of the most common reagents that induce muscle injury. Increased CTSK expression is associated with muscle injury or necrosis in patients with DMD. The lack of muscle weakness in the patient with asymptomatic dystrophinopathy might be attributed to the low CTSK expression in the muscles. To the best of our knowledge, this is the first report to demonstrate that CTSK expression was significantly higher in the skeletal muscles of patients with DMD with a typical phenotype than in those without dystrophinopathy.
引用
收藏
页码:411 / 421
页数:11
相关论文
共 50 条
  • [21] Duchenne muscular dystrophy -: α-dystroglycan immunoexpression in skeletal muscle and cognitive performance
    Pereira, CCD
    Kiyomoto, BH
    Cardoso, R
    Oliveira, ASB
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2005, 63 (04) : 984 - 989
  • [22] TRANSCRIPTION OF THE DYSTROPHIN GENE IN DUCHENNE MUSCULAR-DYSTROPHY MUSCLE
    MUNTONI, F
    STRONG, PN
    FEBS LETTERS, 1989, 252 (1-2) : 95 - 98
  • [23] Modulating fast skeletal muscle contraction protects skeletal muscle in animal models of Duchenne muscular dystrophy
    Russell, Alan J.
    DuVall, Mike
    Barthel, Ben
    Qian, Ying
    Peter, Angela K.
    Newell-Stamper, Breanne L.
    Hunt, Kevin
    Lehman, Sarah
    Madden, Molly
    Schlachter, Stephen
    Robertson, Ben
    Van Deusen, Ashleigh
    Rodriguez, Hector M.
    Vera, Carlos
    Su, Yu
    Claflin, Dennis R.
    V. Brooks, Susan
    Nghiem, Peter
    Rutledge, Alexis
    Juehne, Twlya I.
    Yu, Jinsheng
    Barton, Elisabeth R.
    Luo, Yangyi E.
    Patsalos, Andreas
    Nagy, Laszlo
    Sweeney, H. Lee
    Leinwand, Leslie A.
    Koch, Kevin
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (10):
  • [24] THE DUCHENNE MUSCULAR-DYSTROPHY GENE-PRODUCT IS LOCALIZED IN SARCOLEMMA OF HUMAN SKELETAL-MUSCLE
    ZUBRZYCKAGAARN, EF
    BULMAN, DE
    KARPATI, G
    BURGHES, AHM
    BELFALL, B
    KLAMUT, HJ
    TALBOT, J
    HODGES, RS
    RAY, PN
    WORTON, RG
    NATURE, 1988, 333 (6172) : 466 - 469
  • [25] Erratum to: Cyclooxygenase-2 expression in skeletal muscle of knockout mice suffering Duchenne muscular dystrophy
    Flavia de Oliveira
    Hananiah Tardivo Quintana
    Jeferson André Bortolin
    Odair Alfredo Gomes
    Edson Aparecido Liberti
    Daniel Araki Ribeiro
    Histochemistry and Cell Biology, 2013, 139 (4) : 621 - 621
  • [26] Altered bone-regulating myokine expression in skeletal muscle Of Duchenne muscular dystrophy mouse models
    Zhou, Shumin
    Qian, Baoli
    Wang, Ling
    Zhang, Changqing
    Hogan, Macalus V.
    Li, Hongshuai
    MUSCLE & NERVE, 2018, 58 (04) : 573 - 582
  • [27] Expression of Pannexin 1 and Pannexin 3 during skeletal muscle development, regeneration, and Duchenne muscular dystrophy
    Pham, Tammy L.
    St-Pierre, Marie-Eve
    Ravel-Chapuis, Aymeric
    Parks, Tara E. C.
    Langlois, Stephanie
    Penuela, Silvia
    Jasmin, Bernard J.
    Cowan, Kyle N.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (10) : 7057 - 7070
  • [28] Gene expression profiling of blood in patients with Duchenne muscular dystrophy
    Wong, B.
    Liu, D.
    Hu, S.
    Morehart, P.
    Stamova, B.
    Ander, B.
    Sharp, F.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S253 - S253
  • [29] DUCHENNE MUSCULAR-DYSTROPHY GENE-EXPRESSION IN NORMAL AND DISEASED HUMAN-MUSCLE
    SCOTT, MO
    SYLVESTER, JE
    HEIMANPATTERSON, T
    SHI, YJ
    FIELES, W
    STEDMAN, H
    BURGHES, A
    RAY, P
    WORTON, R
    FISCHBECK, KH
    SCIENCE, 1988, 239 (4846) : 1418 - 1420
  • [30] THE DUCHENNE MUSCULAR-DYSTROPHY GENE - PRODUCTS AND REGULATION OF EXPRESSION
    NUDEL, U
    YAFFE, D
    BAR, S
    BARNEA, E
    GREENBERG, D
    LEDERFEIN, D
    MAKOVER, A
    MARQUEZ, F
    PIZZO, P
    PRIGOJIN, H
    RAPAPORT, D
    ZUK, D
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 473 - 473